Cite
Caraballo L, Valenta R, Puerta L, et al. The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources. World Allergy Organ J. 2020;13(5):100118doi: 10.1016/j.waojou.2020.100118.
Caraballo, L., Valenta, R., Puerta, L., Pomés, A., Zakzuk, J., Fernandez-Caldas, E., Acevedo, N., Sanchez-Borges, M., Ansotegui, I., Zhang, L., van Hage, M., Abel-Fernández, E., Karla Arruda, L., Vrtala, S., Curin, M., Gronlund, H., Karsonova, A., Kilimajer, J., Riabova, K., Trifonova, D., & Karaulov, A. (2020). The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources. The World Allergy Organization journal, 13(5), 100118. https://doi.org/10.1016/j.waojou.2020.100118
Caraballo, Luis, et al. "The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources." The World Allergy Organization journal vol. 13,5 (2020): 100118. doi: https://doi.org/10.1016/j.waojou.2020.100118
Caraballo L, Valenta R, Puerta L, Pomés A, Zakzuk J, Fernandez-Caldas E, Acevedo N, Sanchez-Borges M, Ansotegui I, Zhang L, van Hage M, Abel-Fernández E, Karla Arruda L, Vrtala S, Curin M, Gronlund H, Karsonova A, Kilimajer J, Riabova K, Trifonova D, Karaulov A. The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources. World Allergy Organ J. 2020 Apr 29;13(5):100118. doi: 10.1016/j.waojou.2020.100118. eCollection 2020 May. PMID: 32373267; PMCID: PMC7195550.
Copy
Download .nbib